Avoid common mistakes on your manuscript.
1 Correction to: Drugs R D https://doi.org/10.1007/s40268-017-0209-5
In the Original Publication of the article, In Introduction part, 7th line, the value “5–100 nM” has been published incorrectly. The correct value should read as “Plasma concentration of 50–100 ng/ml”. In the Original Publication of the article, page 591, Table 2 has been published incorrectly. The corrected table is shown below:
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Buti, S., Donini, M., Bersanelli, M. et al. Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study. Drugs R D 18, 163 (2018). https://doi.org/10.1007/s40268-018-0234-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40268-018-0234-z